Publication

Kistner TM, Katsanis E, Simpson RJ. 2026 July. Augmenting β2-adrenergic signaling during exercise to enhance anti-tumor immune function. Exercise and Sport Sciences Reviews. doi:10.1249/jes.0000000000000395.

Leite G S F, Sullivan J, Filioglou D, Kounelis M, Batatinha H, Simpson RJ, Katsanis E. 2026. Blinatumomab bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model. Journal for ImmunoTherapy of Cancer. 14(6):e014890. doi:10.1136/jitc-2026-014890.

Cracchiolo MJ, Simpson RJ, Katsanis E. 2026 May. Post‐Transplant Bendamustine as a Platform for Immune Modulation After Allogeneic Hematopoietic Cell Transplantation. European Journal of Haematology. doi:10.1111/ejh.70215.

Batatinha H, Valenzuela AM, Filioglou D, Wilde P, Leite G, Kistner TM, Baker FL, Katsanis E, Simpson RJ. 2026. Exercise-mobilized lymphocytes enhance the function of cytokine-induced memory-like NK cells against myeloid leukemia. Blood Advances. 10(7):2565–2577. doi:10.1182/bloodadvances.2025018345.

Chou L, Valenzuela AM, McDougal LM, Baker FL, Katsanis E, Simpson RJ. 2026. Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16+ NK cell–mediated cytotoxicity. Journal of Translational Medicine. 24(1). doi:10.1186/s12967-026-07888-7.

Duan S, Zinkeng A, Sawyer T, Merchant J, Twer A, Naciri I, Moore J, Gentry R, Sontz R, Ayabe R, et al. 2026 Feb. 21. Hedgehog signaling drives glial cell plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine neoplasms. Molecular Cancer. doi:10.1186/s12943-026-02611-y.

McKenzie GM, Voss J, Katsanis E, Simpson RJ, Baker FL. 2026. TIGIT Blockade Potentiates the Anti-Leukemic Activity of Exercise-Mobilized Donor Lymphocytes and Expanded γδ T-Cells. Cancers. 18(5):797. doi:10.3390/cancers18050797.

Walsh C, Palazzo L, Hansell L, Louie T, Long S, Brown M, S Hippe D, Coronado G, Decell K, Leone RJ, et al. 2026. Lung cancer screening care pathways in community settings: an examination of 3 healthcare systems. Annals of the American Thoracic Society. doi:10.1093/annalsats/aaoag029.

Chen K, Chen M, Henn D, Berryman K, Sivaraj D, Kussie H, Bonham C, McKenna E, Gracia Mora Pinos M, Alsharif A, et al. 2026. Targeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis. Nature biomedical engineering. doi:10.1038/s41551-025-01479-5.

Thompson AD, McAlister KW, Scholpa NE, Janda J, Hortareas J, Georgieva T, Schnellmann RG. 2025. 5-Hydroxytryptamine 1F receptor loss reduces renal vasculature and prevents lasmiditan-induced recovery following moderate-severe acute kidney injury in mice. American Journal of Physiology-Renal Physiology. 329(6):F834-F852. doi:10.1152/ajprenal.00307.2025.

Liu T, Roorkeewal J, Furlong MA, Beitel SC, Burgess JL, Lee BR, Chipollini J, Snider JM, Batai K. 2025. Evaluating Differential Metabolic Profiles by Prostate Cancer Risk Among Prostate Cancer Patients. Metabolites. 15(12):757. doi:10.3390/metabo15120757.

Larkey LK, James DL, Han S, Weihs K, Jahnke R, Oh B, Kim SW, Huberty J, Petrov ME, Martin D, et al. 2025. Randomized controlled trial testing Tai Chi Easy/Qigong and Sham Qigong on breast cancer survivors’ fatigue and associated symptoms. Complementary Therapies in Clinical Practice. 61:102014. doi:10.1016/j.ctcp.2025.102014.

Adams AC, Macy AM, Borden ES, Herrmann LM, Brambley CA, Sonar SA, Ma T, Li X, Hughes A, Roe DJ, et al. 2025. Structural changes from wild-type define tumor-rejecting neoantigens. Journal for ImmunoTherapy of Cancer. 13(10):e013148. doi:10.1136/jitc-2025-013148.

Borden ES, Hastings CT, Prakash N, Kuo T, Tapia E, Yozwiak M, Sagerman P, Vargas de Stefano D, Buetow KH, Wilson MA, et al. 2025. Towards a transcriptomic biomarker for the classification of melanocytic neoplasms. Sun S, editor. PLOS Genetics. 21(10):e1011869. doi:10.1371/journal.pgen.1011869.

Wang Z, Li W, Jiang Y, Ma T, Li M, Wu S, Tran TB, Cordova LE, Lin E, Scott AJ, et al. 2025 Aug. A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer. Nature Cancer. doi:10.1038/s43018-025-01029-7.

Brown HE, Pauli L, Dholakia R, Gunderson J, Jernberg J, Sanderson PR, Harris RB, Monroy FP. 2025. Helicobacter pylori Diagnostic Testing Accuracy in a High-Prevalence Native American Population of Northern Arizona. Microorganisms. 13(8):1920. doi:10.3390/microorganisms13081920.

Herbst-Kralovetz MM, Gautam N, Łaniewski P, Cui H, Roe D, Chase DM, Jimenez N. 2025 July 19. Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions. Quality of Life Research. doi:10.1007/s11136-025-04031-9.

Chen X, Shen Y, Choi S, Abdel-Hafiz HA, Basu M, Hoelzen L, Tufano M, Kailasam Mani SK, Ranjpour M, Zhu J, et al. 2025. Concurrent loss of the Y chromosome in cancer and T cells impacts outcome. Nature. 642(8069):1041–1050. doi:10.1038/s41586-025-09071-2.

Magnus JH, Nguyen LT, Alevy EG, Sawyer TW, Crossley SD, Kieu K. 2025. Fifth-harmonic and five-photon excitation fluorescence multiphoton microscopy. Optics Letters. 50(12):3931. doi:10.1364/ol.566910.

Chauhan SS, Vizzerra AD, Liou H, Flores CE, Snider AJ, Snider JM, Warfel NA. 2025. Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer. Oncotarget. 16(1):532–544. doi:10.18632/oncotarget.28750.

Jimenez N, Łaniewski P, Chase DM, Caporaso JG, Herbst-Kralovetz MM, Herman C, Lee K, Mahnert N, Cope E. 2025. Navigating complexities of polymorphic microbiomes in endometrial cancer. npj Biofilms and Microbiomes. 11(1):1–8. doi:https://doi.org/10.1038/s41522-025-00690-1.

Sonar SA, Bhat R, Thompson HL, Coplen CP, Uhrlaub JL, Jergović M, Nikolich JŽ. 2025 May. Age‐Related Oxidative Stress and Mitochondrial Dysfunction in Lymph Node Stromal Cells Limit the Peripheral T Cell Homeostatic Maintenance and Function. Aging Cell. doi:10.1111/acel.70100.

Bonaventura J, Lima N, Routh J, Alameri A, Bomman S, Banerjee B, Gavini H, Sawyer T. 2025. Multimodal esophageal cancer imaging: establishing data processing techniques and assessing diagnostic sensitivity. Biophotonics Discovery. 2(02). doi:10.1117/1.bios.2.2.022704.

Abdelrahim M, Esmail A, Kim RD, Arora SP, Arshad J, Kournoutas IA, O’Donnell CD, Totev TI, Tan A, Mu F, et al. 2025. Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study. Cancers. 17(11):1814. doi:10.3390/cancers17111814.

Marcarian HQ, Sivakoses A, Arias AM, Ihedioha OC, Lee BR, Bishop MC, Bothwell ALM. 2025. Renal cancer cells acquire immune surface protein through trogocytosis and horizontal gene transfer. Fujiwara K, editor. PLOS One. 20(5):e0325043. doi:10.1371/journal.pone.0325043.